| Date Filed | Type | Description |
| 08/23/2023 |
4
| Hsieh Ming (CEO) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Disposed of 750,000 options to buy
@ $0
Acquired 750,000 options to buy
@ $0 |
|
| 08/21/2023 |
4
| Xie Jian (President and COO) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Sold 1,307 shares
@ $33.8811, valued at
$44.3k
|
|
| 08/21/2023 |
4
| Kim Paul (CFO and Treasurer) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Sold 491 shares
@ $33.8811, valued at
$16.6k
Sold 1,307 shares
@ $33.8811, valued at
$44.3k
|
|
| 08/21/2023 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Sold 342 shares
@ $33.8811, valued at
$11.6k
|
|
| 08/07/2023 |
4
| Xie Jian (President and COO) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Paid exercise price by delivering 6,198 shares
@ $40.08, valued at
$248.4k
|
|
| 08/07/2023 |
4
| Kim Paul (CFO and Treasurer) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Paid exercise price by delivering 1,240 shares
@ $40.08, valued at
$49.7k
|
|
| 08/03/2023 |
4
| Xie Jian (President and COO) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Paid exercise price by delivering 775 shares
@ $38.83, valued at
$30.1k
|
|
| 08/03/2023 |
4
| Hsieh Ming (CEO) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Paid exercise price by delivering 4,783 shares
@ $38.83, valued at
$185.7k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2023 |
4
| Xie Jian (President and COO) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Sold 1,433 shares
@ $40.2961, valued at
$57.7k
|
|
| 06/06/2023 |
4
| Kim Paul (CFO and Treasurer) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Sold 1,403 shares
@ $40.2961, valued at
$56.5k
|
|
| 06/06/2023 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Sold 1,000 shares
@ $40.2961, valued at
$40.3k
|
|
| 05/19/2023 |
4
| Xie Jian (President and COO) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Sold 1,320 shares
@ $35.4623, valued at
$46.8k
|
|
| 05/19/2023 |
4
| Kim Paul (CFO and Treasurer) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Sold 921 shares
@ $35.4623, valued at
$32.7k
Sold 345 shares
@ $35.4623, valued at
$12.2k
|
|
| 05/19/2023 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Sold 345 shares
@ $35.4623, valued at
$12.2k
|
|
| 05/05/2023 |
4
| Xie Jian (President and COO) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Paid exercise price by delivering 6,198 shares
@ $29.33, valued at
$181.8k
|
|
| 05/05/2023 |
4
| Kim Paul (CFO and Treasurer) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Paid exercise price by delivering 865 shares
@ $29.33, valued at
$25.4k
|
|
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Paid exercise price by delivering 76 shares
@ $29.57, valued at
$2.2k
|
|
| 03/01/2023 |
4
| Xie Jian (President and COO) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Paid exercise price by delivering 433 shares
@ $32.67, valued at
$14.1k
|
|
| 02/27/2023 |
4
| Xie Jian (President and COO) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Granted 2,142 shares
@ $0
Granted 14,573 shares
@ $0
Paid exercise price by delivering 741 shares
@ $31.65, valued at
$23.5k
|
|
| 02/27/2023 |
4
| KIM PAUL (CFO and Treasurer) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Granted 2,142 shares
@ $0
Granted 14,218 shares
@ $0
Paid exercise price by delivering 741 shares
@ $31.65, valued at
$23.5k
|
|
| 02/27/2023 |
4
| Hsieh Ming (CEO) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Granted 7,616 shares
@ $0
Granted 47,393 shares
@ $0
Paid exercise price by delivering 2,625 shares
@ $31.65, valued at
$83.1k
|
|
| 02/27/2023 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Granted 2,142 shares
@ $0
Granted 12,156 shares
@ $0
Paid exercise price by delivering 794 shares
@ $31.65, valued at
$25.1k
|
|
| 02/07/2023 |
4
| Xie Jian (President and COO) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Paid exercise price by delivering 4,408 shares
@ $36.21, valued at
$159.6k
|
|
| 02/07/2023 |
4
| KIM PAUL (CFO and Treasurer) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Paid exercise price by delivering 1,020 shares
@ $36.21, valued at
$36.9k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| GROVES REGINA E (Director) has filed a Form 4 on Fulgent Genetics, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 10,000 options to buy
@ $30.66, valued at
$306.6k
|
|
| 01/04/2023 |
3
| GROVES REGINA E (Director) has filed a Form 3 on Fulgent Genetics, Inc. |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|